Key facts
- This page summarizes Thomas B. Smith MD's Form 4 filing for COLLEGIUM PHARMACEUTICAL, INC (COLL).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 12 Feb 2025, 16:10.
Thomas B. Smith MD - 10 Feb 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)
- Reporting relationship
- EVP and Chief Medical Officer
- Issuer ticker
- COLL
- Reported as of
- 10 Feb 2025
- Net transaction value
- -$179,976
- SEC form
- 4
- Accepted by SEC
- 12 Feb 2025, 16:10:38 UTC
- Prior SEC filing
- 17 Sep 2024
- Next SEC filing
- 03 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Shirley R. Kuhlmann as Attorney-In-Fact For Thomas B. Smith, MD
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas B. Smith MD filed Form 4 for COLLEGIUM PHARMACEUTICAL, INC (COLL) on 12 Feb 2025.
Change
- Previous filing in this sequence was filed on 17 Sep 2024.
- Current net transaction value: -$179,976.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
COLL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +33,762
- Change %
- +62%
- Price
- $0.000000
- Shares after
- 88,326
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F1, F2
COLL
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,313
- Change %
- +6%
- Price
- $0.000000
- Shares after
- 93,639
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F3
COLL
transaction
Common Stock
Tax liability
- Transaction value
- $45,719
- Shares
- -1,498
- Change %
- -1.6%
- Price
- $30.52
- Shares after
- 92,141
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F4
COLL
transaction
Common Stock
Tax liability
- Transaction value
- $134,257
- Shares
- -4,399
- Change %
- -4.8%
- Price
- $30.52
- Shares after
- 87,742
- Date
- 10 Feb 2025
- Ownership
- Direct
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
Footnote F2
Includes 373 and 375 shares acquired on July 19, 2024 and January 17, 2025, respectively, under the Issuer's employee stock purchase plan.
Footnote F3
Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 5,313 performance share units ("PSUs") granted in the Issuer's prior fiscal year.
Footnote F4
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
Footnote F5
Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.